IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹969 Cr | ₹1,014 Cr | ₹902 Cr | ₹614 Cr | ₹190 Cr |
What is the latest Total Non-Current Liabilities ratio of IPCA LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹969 Cr |
| Mar2024 | ₹1,014 Cr |
| Mar2023 | ₹902 Cr |
| Mar2022 | ₹614 Cr |
| Mar2021 | ₹190 Cr |
How is Total Non-Current Liabilities of IPCA LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹969 Cr | -4.46 | |
| Mar2024 | ₹1,014 Cr | 12.50 | |
| Mar2023 | ₹902 Cr | 46.89 | |
| Mar2022 | ₹614 Cr | 223.62 | |
| Mar2021 | ₹190 Cr | - | |
Compare Total Non-Current Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹45,350.1 Cr | 0.4% | 9.4% | 25.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 0.4% |
9.4% |
25.1% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses